Compare Edwards Lifesciences Corporation Common Stock (EW) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Lockheed Martin Corporation — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Lockheed Martin Corporation trades at $507.02 (market cap $115.22B). The key difference: Lockheed Martin Corporation is far larger — about 2.3× Edwards Lifesciences Corporation Common Stock's market cap, and Lockheed Martin Corporation pays a 2.76% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | LMT | |
|---|---|---|
Market Cap | $49.44B | $115.22B |
Volume | 3,508,027 | 1,073,075 |
Sector | Health | Industrials |
52-Week High | $95.18 | $676.70 |
52-Week Low | $72.65 | $439.19 |
Enterprise Value | $45.90B | $131.96B |
Typical Hold Time | — | 86 Days |
Dividend Yield | — | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lockheed Martin (LMT) trades at $507.89, down 0.44% on the day, with a bearish technical signal driven by moving averages. The stock shows strong profitability with an 8.16% net margin and 89.16% ROE, but recent earnings missed expectations in two of the last three quarters. Revenue growth is steady, projected to reach $77B in 2026, while analyst sentiment remains positive with a $645.50 consensus price target. Recent news highlights dividend increases and AI integration initiatives.
The outlook for LMT is supported by robust defense spending and a high analyst buy rating (59%), but risks include fixed-price contract volatility and debt levels. The stock offers a dividend yield near 0.7% with 23 consecutive years of increases. Upside potential exists if earnings rebound, though technical resistance near $510 may cap near-term gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
